Walmart weed scale purchase
Will Canadian Cannabis Producer Aphria Join The M&A Bandwagon?
Could Smaller Pot Companies Be Targets After The Constellation – Canopy Deal?
Here’s Why We Believe Canadian Medical Cannabis Producer Aphria Is Worth CAD 12.60 Per Share
Medical Marijuana Producer Aphria’s International Expansion Plans To Drive Its Value In The Long Term
Cronos Group Earnings Preview: Looking For Updates On Capacity Expansion Plans
Altria’s Sales Woes Continue In The Second Quarter
Can Altria’s Second Quarter Performance Result In A Rise In the Stock Price?
Restrictions On Packaging & Branding Could Hamper Canadian Cannabis Producer Canopy Growth’s Sales
Why A High Valuation For Aurora Cannabis Makes Sense
How FDA Concerns Have Made Altria An Undervalued Stock
How Does Medical Cannabis Producer Canopy Growth Plan To Cater To The Newly Opened Recreational Marijuana Market Marijuana Scale Chart And Prices
Medical Marijuana Producer Canopy Growth – Undervalued Or Overvalued?
What Is Driving The Rally In Cronos Group’s Stock?
The Cronos Group (NASDAQ: CRON) (TOR: CRON.TO), a vertically integrated Canadian marijuana company, published its second-quarter results on August 14. The company’s financial results are not particularly consequential at the moment, with revenues standing at just $3.4 million for the quarter, up from around $600k in the year-ago period, driven by patient on-boarding, higher prices and growth in its cannabis oil offering. However, the company indicated that it was on track to bolster its capacity expansion, which we view as a key near-term driver to its overall growth.
We have created an interactive dashboard analysis on
which allows users to modify any of our forecasts and drivers to arrive at their own valuation estimates for the company.
Will Canadian Cannabis Producer Aphria Join The M&A Bandwagon?
Could Smaller Pot Companies Be Targets After The Constellation – Canopy Deal?
Here’s Why We Believe Canadian Medical Cannabis Producer Aphria Is Worth CAD 12.60 Per Share
Medical Marijuana Producer Aphria’s International Expansion Plans To Drive Its Value In The Long Term
Cronos Group Earnings Preview: Looking For Updates On Capacity Expansion Plans
Altria’s Sales Woes Continue In The Second Quarter
Cronos needs to aggressively scale up its manufacturing capacity and production volumes, as its home market of Canada looks set to begin the sale of recreational marijuana to adult consumers, and also as the company continues to expand into international markets. During its Q2 earnings call, management noted that the construction of the company’s 286k square foot purpose-built indoor production facility located in Ontario remains on track. The facility, which will be the largest purpose-built indoor cannabis facility in the world, is currently preparing for planting. Separately, in July, Cronos announced a strategic joint venture to construct an 850k square foot greenhouse for cannabis production. Once fully operational, the facility is expected to produce up to 70k kilograms of cannabis annually. Additionally, the company’s Australian business was granted a license to manufacture medicinal cannabis, bringing it closer towards full-scale operations in the country.
The broader market for marijuana stocks saw a significant rally on Wednesday after beer maker Constellation Brands announced that it would boost its stake in Canopy Growth with a $4 billion investment, marking the single largest investment in the cannabis space. The deal has boosted sentiment around other marijuana stocks, such as Cronos, as the market likely expects that other food and beverage companies could seek out similar deals with cannabis producers. Moreover, there is a possibility that Constellation itself could acquire other rivals in order to boost its capacity using its sizable cash holdings. Cronos group saw its stock rise by about 12% to about
What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs
Why Halliburton’s U.S. Business Could Face Some Headwinds
What Will Drive Boeing’s Growth In The Near Term?
Could Smaller Pot Companies Be Targets After The Constellation – Canopy Deal?
What Will Drive Intuitive Surgical’s Near Term Growth
Bitcoin Now Looks Unlikely To Cross $10,000 Again This Year
Why Is PepsiCo Paying Such A High Price For SodaStream?
Thanks for signing up!Please check your inbox for an important e-mail from us.
I would point out that the Department of Health will adopt the 'mixed' approach to ecig regulation contained in TPD2 (Article 20).The MHRA has been...
Although points 1 and 3 are sound in thought process, the analysis for point 2 overlooks a very important detail. The author is forgetting RJR's VU...
Will Canadian Cannabis Producer Aphria Join The M&A Bandwagon?
How Is Costco Likely To Grow In The Next 2 Years?
000 Again This Year Marijuana Scale Chart And Prices ,000 Again This Year
0 Reviews:
Post Your Review